GURUFOCUS.COM » STOCK LIST » Technology » Software » Vaxxa AB (XSAT:VAXXA) » Definitions » Capex-to-Revenue

Vaxxa AB (XSAT:VAXXA) Capex-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Vaxxa AB Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Vaxxa AB's Capital Expenditure for the three months ended in Mar. 2024 was kr0.00 Mil. Its Revenue for the three months ended in Mar. 2024 was kr20.54 Mil.

Hence, Vaxxa AB's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.00.


Vaxxa AB Capex-to-Revenue Historical Data

The historical data trend for Vaxxa AB's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxxa AB Capex-to-Revenue Chart

Vaxxa AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial - 0.45 0.01 - -

Vaxxa AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vaxxa AB's Capex-to-Revenue

For the Software - Application subindustry, Vaxxa AB's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxxa AB's Capex-to-Revenue Distribution in the Software Industry

For the Software industry and Technology sector, Vaxxa AB's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Vaxxa AB's Capex-to-Revenue falls into.



Vaxxa AB Capex-to-Revenue Calculation

Vaxxa AB's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 52.922
=0.00

Vaxxa AB's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 20.535
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vaxxa AB  (XSAT:VAXXA) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Vaxxa AB Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Vaxxa AB's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaxxa AB (XSAT:VAXXA) Business Description

Traded in Other Exchanges
N/A
Address
Maskinvagen 27, Norrbotten, Lulea, SWE, 972 54
Vaxxa AB is the auction site for those who want to buy and sell objects in vehicles, machinery, construction and industry. The company want to make it more accessible for both private individuals and companies to sell their objects with the motivation to pave the way for a more circular market. Vaxxa is Sweden's only auction platform where exactly the combination of auction broker and self-service is offered.

Vaxxa AB (XSAT:VAXXA) Headlines

No Headlines